{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:27Z","timestamp":1787020167684,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["NO. 2022-1G-2161"],"award-info":[{"award-number":["NO. 2022-1G-2161"]}]},{"name":"the National Key R&D Program of China","award":["NO. 2022YFC2305200"],"award-info":[{"award-number":["NO. 2022YFC2305200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Screening for Tuberculosis (TB) is a critical tactic for minimizing the prevalence of illness within schools. Tuberculosis Preventive Therapy (TPT), in turn, effectively staves off the development of TB from latent tuberculosis infection (LTBI). Unfortunately, there is limited research on LTBI and TPT among students. This study aimed to assess LTBI among freshmen in Changping District and advocate for the implementation of TPT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The prospective study collected data from 12 educational institutions within the Changping District of Beijing. The Kolmogorov\u2009\u2212\u2009Smirnov test and other statistical methods were used for statistical analysis,\n                      <jats:inline-formula>\n                        <jats:alternatives>\n                          <jats:tex-math>$${x}^{2}$$<\/jats:tex-math>\n                          <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                            <mml:msup>\n                              <mml:mrow>\n                                <mml:mi>x<\/mml:mi>\n                              <\/mml:mrow>\n                              <mml:mn>2<\/mml:mn>\n                            <\/mml:msup>\n                          <\/mml:math>\n                        <\/jats:alternatives>\n                      <\/jats:inline-formula>\n                      was obtained using the formula\n                      <jats:inline-formula>\n                        <jats:alternatives>\n                          <jats:tex-math>$${x}^{2}=$$<\/jats:tex-math>\n                          <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                            <mml:mrow>\n                              <mml:msup>\n                                <mml:mrow>\n                                  <mml:mi>x<\/mml:mi>\n                                <\/mml:mrow>\n                                <mml:mn>2<\/mml:mn>\n                              <\/mml:msup>\n                              <mml:mo>=<\/mml:mo>\n                            <\/mml:mrow>\n                          <\/mml:math>\n                        <\/jats:alternatives>\n                      <\/jats:inline-formula>\n                      n\u03a3A\n                      <jats:sup>2<\/jats:sup>\n                      \/n\n                      <jats:sub>R<\/jats:sub>\n                      n\n                      <jats:sub>C<\/jats:sub>\n                      -1, df\u2009=\u2009(C-1) (R-1). We analyzed potential factors impacting the LTBI rate, and scrutinized the possible causes behind the low application of TPT and its efficacy for LTBI treatment, China.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 19,872 freshmen included in this study, 18 active TB cases (91 per 10,0000) and 2236 LTBI cases (11.6% of 19,223) were identified, respectively. Furthermore, of those with LTBI, 1045 (5.4% of 19,223) showed a strong positive for purified protein derivative (PPD), but only 312 opted for TB preventive treatment. There appeared to be no significant difference in the prevalence of LTBI and TPT rate between male and female students. Concurrently, 11 (71 per 100,000) and 7 (158 per 100,000) cases of active tuberculosis were identified in 6 universities and 6 higher vocational colleges, respectively. Interestingly, almost all freshmen who underwent TPT came from universities, suggesting a statistically significant disparity in TPT rate (\u03c72\u2009=\u2009139.829,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) between these two types of educational institutions. Meanwhile, as for the age-wise distribution of latent infection among 17\u201320\u00a0years old freshmen, the LTBI rate exhibited 10.5%, 11.6%, 12.1% and 13.5%, respectively. Correlation between LTBI rate, the strong positive rate was statistically significant among different ages (\u03c72\u2009=\u200934.559,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Over a follow-up period of 2\u00a0years, three students were diagnosed with active tuberculosis, one of which was resistant to rifampicin. All three students manifested a strong positive for PPD and declined preventive treatment during TB screening.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The data indicates a high rate of LTBI amongst students in areas with a heavy TB burden, potentially leading to cross-regional TB transmission due to the migration of students. Education level might contribute to the limited uptake of TPT. Therefore, improving the implementation of TB preventive treatments is crucial in controlling and preventing TB across schools.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-023-08802-y","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T19:02:29Z","timestamp":1702321349000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Tuberculosis screening characteristics amongst freshmen in Changping District, Beijing, China"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiaolong","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zexuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"issue":"4","key":"8802_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/microbiolspec.GPP3-0022-2018","volume":"7","author":"JK Sia","year":"2019","unstructured":"Sia JK, Rengarajan J. Immunology of Mycobacterium tuberculosis Infections. Microbiol Spectr. 2019;7(4):10\u2013128.","journal-title":"Microbiol Spectr."},{"issue":"321\u2013326","key":"8802_CR2","first-page":"322","volume":"122","author":"W Huang","year":"2022","unstructured":"Huang W, Fang Z, Luo S, et al. The effect of BCG vaccination and risk factors for latent tuberculosis infection among college freshmen in China. Int J Infect Dis. 2022;122(321\u2013326):322.","journal-title":"Int J Infect Dis"},{"key":"8802_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.947852","volume":"13","author":"P Cheng","year":"2022","unstructured":"Cheng P, Wang L, Gong W. In silico analysis of peptide-based biomarkers for the diagnosis and prevention of latent tuberculosis infection. Front Microbiol. 2022;13: 947852.","journal-title":"Front Microbiol"},{"issue":"8","key":"8802_CR4","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3390\/biom12081148","volume":"12","author":"MT Herrera","year":"2022","unstructured":"Herrera MT, Guzman-Beltran S, Bobadilla K, et al. Human Pulmonary Tuberculosis: Understanding the Immune Response in the Bronchoalveolar System. Biomolecules. 2022;12(8):1148.","journal-title":"Biomolecules"},{"key":"8802_CR5","doi-asserted-by":"crossref","unstructured":"Boom WH, Schaible UE, Achkar JM. The knowns and unknowns of latent Mycobacterium tuberculosis infection. J Clin Invest. 2021;131(3):e136222.","DOI":"10.1172\/JCI136222"},{"key":"8802_CR6","doi-asserted-by":"crossref","unstructured":"Munoz L, Stagg HR, Abubakar I. Diagnosis and Management of Latent Tuberculosis Infection. Cold Spring Harb Perspect Med. 2015;5(11):a017830.","DOI":"10.1101\/cshperspect.a017830"},{"key":"8802_CR7","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.ijid.2020.05.009","volume":"96","author":"JY Feng","year":"2020","unstructured":"Feng JY, Huang WC, Lin SM, et al. Safety and treatment completion of latent tuberculosis infection treatment in the elderly population-A prospective observational study in Taiwan. Int J Infect Dis. 2020;96:550\u20137.","journal-title":"Int J Infect Dis"},{"key":"8802_CR8","doi-asserted-by":"publisher","first-page":"1095467","DOI":"10.3389\/fcdhc.2023.1095467","volume":"4","author":"NP Kumar","year":"2023","unstructured":"Kumar NP, Babu S. Impact of diabetes mellitus on immunity to latent tuberculosis infection. Front Clin Diabetes Healthc. 2023;4:1095467.","journal-title":"Front Clin Diabetes Healthc"},{"key":"8802_CR9","first-page":"2157","volume":"13","author":"K Karbito","year":"2022","unstructured":"Karbito K, Susanto H, Adi MS, et al. Latent tuberculosis infection in family members in household contact with active tuberculosis patients in Semarang City, Central Java. Indonesia J Public Health Afr. 2022;13:2157.","journal-title":"Indonesia. J Public Health Afr"},{"key":"8802_CR10","doi-asserted-by":"crossref","unstructured":"Bagcchi S. WHO's Global Tuberculosis Report 2022. Lancet Microbe. 2023;4(1):e20.","DOI":"10.1016\/S2666-5247(22)00359-7"},{"key":"8802_CR11","doi-asserted-by":"publisher","first-page":"e948","DOI":"10.1016\/S2468-2667(21)00203-6","volume":"6","author":"Q Long","year":"2021","unstructured":"Long Q, Guo L, Jiang W, et al. Ending tuberculosis in China: health system challenges. Lancet Public Health. 2021;6:e948\u201353.","journal-title":"Lancet Public Health"},{"key":"8802_CR12","doi-asserted-by":"crossref","unstructured":"Dong Z, Wang QQ, Yu SC, et al. Age-period-cohort analysis of pulmonary tuberculosis reported incidence, China, 2006\u20132020. Infect Dis Pov. 2022;11(1):85.","DOI":"10.1186\/s40249-022-01009-4"},{"key":"8802_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijid.2019.07.004","volume":"87","author":"NI Paton","year":"2019","unstructured":"Paton NI, Borand L, Benedicto J, et al. Diagnosis and management of latent tuberculosis infection in Asia: Review of current status and challenges. Int J Infect Dis. 2019;87:21\u20139.","journal-title":"Int J Infect Dis"},{"key":"8802_CR14","doi-asserted-by":"crossref","unstructured":"Zielinski N, Stranzinger J, Zeeb H, et al. Latent Tuberculosis Infection among Health Workers in Germany-A Retrospective Study on Progression Risk and Use of Preventive Therapy. Int J Environ Res Public Health. 2021;18(13):7053.","DOI":"10.3390\/ijerph18137053"},{"key":"8802_CR15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12879-017-2301-4","volume":"17","author":"P Auguste","year":"2017","unstructured":"Auguste P, Tsertsvadze A, Pink J, et al. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis. BMC Infect Dis. 2017;17:200.","journal-title":"BMC Infect Dis"},{"key":"8802_CR16","first-page":"317","volume":"31","author":"Y Li","year":"2018","unstructured":"Li Y, Zheng YH, Lu LP, et al. Acceptance of Chemo-prophylaxis for Latent Tuberculosis Infection among High School\/College Student Contacts of Tuberculosis Patients in Shanghai. China Biomed Environ Sci. 2018;31:317\u201321.","journal-title":"China. Biomed Environ Sci"},{"key":"8802_CR17","doi-asserted-by":"publisher","first-page":"737","DOI":"10.6002\/ect.2021.0186","volume":"20","author":"M Pakfetrat","year":"2022","unstructured":"Pakfetrat M, Malekmakan L, Hamidianjahromi A, et al. Diagnosis and treatment of latent tuberculosis infection in kidney and liver transplant recipients in iranian candidates for transplant. Exp Clin Transpl. 2022;20:737\u201341.","journal-title":"Exp Clin Transpl"},{"key":"8802_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijid.2016.11.006","volume":"56","author":"GJ Fox","year":"2017","unstructured":"Fox GJ, Dobler CC, Marais BJ, et al. Preventive therapy for latent tuberculosis infection-the promise and the challenges. Int J Infect Dis. 2017;56:68\u201376.","journal-title":"Int J Infect Dis"},{"key":"8802_CR19","volume":"10","author":"A Anand","year":"2018","unstructured":"Anand A, Wagner C, Kong SS, et al. Improving screening for latent tuberculosis infection in a student-run free clinic. Cureus. 2018;10: e2488.","journal-title":"Cureus"},{"key":"8802_CR20","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1177\/00333549221148173","volume":"138","author":"SM Marks","year":"2023","unstructured":"Marks SM, Self JL, Venkatappa T, et al. Diagnosis, treatment, and prevention of tuberculosis among people experiencing homelessness in the United States: Current recommendations. Public Health Rep. 2023;138:896\u2013907.","journal-title":"Public Health Rep"},{"key":"8802_CR21","doi-asserted-by":"crossref","unstructured":"Koff A, Azar MM. Diagnosing peritoneal tuberculosis. BMJ Case Rep. 2020;13(2):e233131.","DOI":"10.1136\/bcr-2019-233131"},{"key":"8802_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1186\/s12879-019-4238-2","volume":"19","author":"D Cao","year":"2019","unstructured":"Cao D, Zhang Z, Yang Z, et al. The association between tuberculin skin test result and active tuberculosis risk of college students in Beijing, China: a retrospective cohort study. BMC Infect Dis. 2019;19:619.","journal-title":"BMC Infect Dis"},{"key":"8802_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ijid.2018.09.019","volume":"78","author":"D Pan","year":"2019","unstructured":"Pan D, Lan R, Graviss EA, et al. Adolescent tuberculosis associated with tuberculosis exposure in classrooms and dorm rooms in Guangxi. China Int J Infect Dis. 2019;78:8\u201314.","journal-title":"China. Int J Infect Dis"},{"key":"8802_CR24","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s11845-021-02779-w","volume":"191","author":"J O'Connell","year":"2022","unstructured":"O\u2019Connell J, de Barra E, McConkey S. Systematic review of latent tuberculosis infection research to inform programmatic management in Ireland. Ir J Med Sci. 2022;191:1485\u2013504.","journal-title":"Ir J Med Sci"},{"key":"8802_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250387","volume":"16","author":"U von Both","year":"2021","unstructured":"von Both U, Gerlach P, Ritz N, et al. Management of childhood and adolescent latent tuberculous infection (LTBI) in Germany Austria and Switzerland. PLoS One. 2021;16: e0250387.","journal-title":"PLoS One"},{"key":"8802_CR26","doi-asserted-by":"crossref","unstructured":"Xin H, Cao X, Zhang H, et al. Protective efficacy of 6-week regimen for latent tuberculosis infection treatment in rural China: 5-year follow-up of a randomised controlled trial. Eur Respir J. 2022;60(1):2102359.","DOI":"10.1183\/13993003.02359-2021"},{"key":"8802_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124097","volume":"10","author":"G He","year":"2015","unstructured":"He G, Li Y, Zhao F, et al. The prevalence and incidence of latent tuberculosis infection and its associated factors among village doctors in China. PLoS One. 2015;10: e0124097.","journal-title":"PLoS One"},{"key":"8802_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12879-023-08005-5","volume":"23","author":"Y Yuan","year":"2023","unstructured":"Yuan Y, Jin J, Bi X, et al. Factors associated with refusal of preventive therapy after initial willingness to accept treatment among college students with latent tuberculosis infection in Shandong. China BMC Infect Dis. 2023;23:38.","journal-title":"China. BMC Infect Dis"},{"key":"8802_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247564","volume":"16","author":"Y Fang","year":"2021","unstructured":"Fang Y, Ma Y, Lu Q, et al. An outbreak of pulmonary tuberculosis and a follow-up investigation of latent tuberculosis in a high school in an eastern city in China, 2016\u20132019. PLoS One. 2021;16: e0247564.","journal-title":"PLoS One"},{"key":"8802_CR30","unstructured":"Wang Qian LT, Du Xin,NI Ni,ZhaO Yan-lin, Zhang Hui. The analysis of national tuberculosis reported incidence and mortality, 2015\u20132019. Chin J Antituberc 2021;43:2."},{"key":"8802_CR31","first-page":"729","volume":"116","author":"I Suarez","year":"2019","unstructured":"Suarez I, Funger SM, Kroger S, et al. The diagnosis and treatment of tuberculosis. Dtsch Arztebl Int. 2019;116:729\u201335.","journal-title":"Dtsch Arztebl Int"},{"key":"8802_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141511","volume":"10","author":"C Chen","year":"2015","unstructured":"Chen C, Zhu T, Wang Z, et al. High latent TB infection rate and associated risk factors in the eastern China of low TB Incidence. PLoS One. 2015;10: e0141511.","journal-title":"PLoS One"},{"key":"8802_CR33","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1186\/s12879-021-06633-3","volume":"21","author":"H Alsdurf","year":"2021","unstructured":"Alsdurf H, Empringham B, Miller C, et al. Tuberculosis screening costs and cost-effectiveness in high-risk groups: a systematic review. BMC Infect Dis. 2021;21:935.","journal-title":"BMC Infect Dis"},{"key":"8802_CR34","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jsps.2020.01.011","volume":"28","author":"F Imam","year":"2020","unstructured":"Imam F, Sharma M, Khayyam KU, et al. Adverse drug reaction prevalence and mechanisms of action of first-line anti-tubercular drugs. Saudi Pharm J. 2020;28:316\u201324.","journal-title":"Saudi Pharm J"},{"key":"8802_CR35","doi-asserted-by":"publisher","first-page":"339","DOI":"10.7196\/SAMJ.8290","volume":"104","author":"GJ Churchyard","year":"2014","unstructured":"Churchyard GJ, Chaisson RE, Maartens G, et al. Tuberculosis preventive therapy: an underutilised strategy to reduce individual risk of TB and contribute to TB control. S Afr Med J. 2014;104:339\u201343.","journal-title":"S Afr Med J"},{"key":"8802_CR36","doi-asserted-by":"crossref","unstructured":"Zenner D, Beer N, Harris RJ, et al. Treatment of Latent Tuberculosis Infection An Updated Network Meta-analysis. Ann Int Med. 2017;167:248-+.","DOI":"10.7326\/M17-0609"},{"key":"8802_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.778028","volume":"12","author":"P Kumar","year":"2021","unstructured":"Kumar P. A Perspective on the Success and Failure of BCG. Front Immunol. 2021;12: 778028.","journal-title":"Front Immunol"},{"key":"8802_CR38","doi-asserted-by":"publisher","first-page":"16418","DOI":"10.18632\/oncotarget.23995","volume":"9","author":"S He","year":"2018","unstructured":"He S, Yang S, Zhao Q, et al. Association of IL4, IL6, and IL10 polymorphisms with pulmonary tuberculosis in a Tibetan Chinese population. Oncotarget. 2018;9:16418\u201326.","journal-title":"Oncotarget"},{"key":"8802_CR39","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2147\/PPA.S252448","volume":"14","author":"J Zhang","year":"2020","unstructured":"Zhang J, Yang Y, Qiao X, et al. Factors influencing medication nonadherence to pulmonary tuberculosis treatment in Tibet, China: A qualitative study from the patient perspective. Patient Prefer Adherence. 2020;14:1149\u201358.","journal-title":"Patient Prefer Adherence"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08802-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08802-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08802-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T07:03:50Z","timestamp":1702364630000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08802-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8802"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08802-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3280858\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,12]]},"assertion":[{"value":"21 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TB screening was investigated after the written informed consent of the freshmen, the research methods and protocols for the current study were carried out in accordance with relevant guidelines and regulations (declarations of Helsinki), which has been approved by The Ethics Committee of Beijing Changping Institute for Tuberculosis Prevention and Treatment (CJ-2020\u2013001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"869"}}